These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 19716825)

  • 41. Cystamine prevents ischemia-reperfusion injury by inhibiting polyamination of RhoA.
    Shin DM; Kang J; Ha J; Kang HS; Park SC; Kim IG; Kim SJ
    Biochem Biophys Res Commun; 2008 Jan; 365(3):509-14. PubMed ID: 17999914
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Compensatory function of bradykinin B1 receptor in the inhibitory effect of captopril on cardiomyocyte hypertrophy and cardiac fibroblast proliferation in neonatal rats.
    Zou J; Ren JH; Feng D; Wang H; Xu J
    Chin Med J (Engl); 2008 Jul; 121(13):1220-5. PubMed ID: 18710643
    [TBL] [Abstract][Full Text] [Related]  

  • 43. RhoA/ROCK I signalling downstream of the P2Y13 ADP-receptor controls HDL endocytosis in human hepatocytes.
    Malaval C; Laffargue M; Barbaras R; Rolland C; Peres C; Champagne E; Perret B; Tercé F; Collet X; Martinez LO
    Cell Signal; 2009 Jan; 21(1):120-7. PubMed ID: 18948190
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Role of RhoA in Neovascular-Related Functions of Endothelial Progenitor Cells Induced by AngiotensinⅡ.
    Yang JX; Pan YY; Chen B; Qiu YG; Mao W; Hu SJ
    Cell Physiol Biochem; 2018; 47(6):2498-2510. PubMed ID: 29991018
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synergism of simvastatin with losartan prevents angiotensin II-induced cardiomyocyte apoptosis in vitro.
    Xu J; Lü XW; Huang Y; Zhu PL; Li J
    J Pharm Pharmacol; 2009 Apr; 61(4):503-10. PubMed ID: 19298698
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Angiotensin II increases secreted frizzled-related protein 5 (sFRP5) expression through AT1 receptor/Rho/ROCK1/JNK signaling in cardiomyocytes.
    Jin X; Guo B; Yan J; Yang R; Chang L; Wang Y; Miao C; Liu S; Zhang H; Li Y
    Mol Cell Biochem; 2015 Oct; 408(1-2):215-22. PubMed ID: 26126628
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Small G-protein Rho is involved in the maintenance of cardiac myocyte morphology.
    Grounds HR; Ng DC; Bogoyevitch MA
    J Cell Biochem; 2005 Jun; 95(3):529-42. PubMed ID: 15786512
    [TBL] [Abstract][Full Text] [Related]  

  • 48. RhoA/Rho-kinase pathway: much more than just a modulation of vascular tone. Evidence from studies in humans.
    Calò LA; Pessina AC
    J Hypertens; 2007 Feb; 25(2):259-64. PubMed ID: 17211228
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Relationship between RhoA/Rho-kinase signaling pathway and penile erection].
    Zhu PY; Jiang R
    Zhonghua Nan Ke Xue; 2008 Feb; 14(2):155-8. PubMed ID: 18390182
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CYP2J2 metabolites, epoxyeicosatrienoic acids, attenuate Ang II-induced cardiac fibrotic response by targeting Gα
    He Z; Yang Y; Wen Z; Chen C; Xu X; Zhu Y; Wang Y; Wang DW
    J Lipid Res; 2017 Jul; 58(7):1338-1353. PubMed ID: 28554983
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of farnesyl pyrophosphate synthase prevents angiotensin II-induced cardiac fibrosis in vitro.
    Li Z; Bi X; Wang M; Zhang J; Song J; Shen X; Han J; Fu G; Ye Y
    Clin Exp Immunol; 2014 Jun; 176(3):429-37. PubMed ID: 24527834
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Kamolonol suppresses angiotensin II-induced stress fiber formation and cellular hypertrophy through inhibition of Rho-associated kinase 2 activity.
    Kim MS; Oh KS; Lee JH; Ryu SY; Mun J; Lee BH
    Biochem Biophys Res Commun; 2013 Aug; 438(2):318-23. PubMed ID: 23891689
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Protective effect of Salvia miltiorrhiza on angiotensin II-induced hypertrophic responses in neonatal rat cardiac cells.
    Ouyang X; Takahashi K; Komatsu K; Nakamura N; Hattori M; Baba A; Azuma J
    Jpn J Pharmacol; 2001 Dec; 87(4):289-96. PubMed ID: 11829148
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Rho-associated protein kinase is involved in establishing the contractile phenotype of cardiomyocytes].
    Stepanova OV; Chadin AV; Masiutin AG; Kulikova TG; Gurin IaV; Sergeeva IA; Shirinskiĭ VP
    Biofizika; 2010; 55(5):880-5. PubMed ID: 21033356
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Zoledronate attenuates angiogenic effects of angiotensin II-stimulated endothelial progenitor cells via RhoA and MAPK signaling.
    Yang JX; Chen B; Pan YY; Han J; Chen F; Hu SJ
    PLoS One; 2012; 7(10):e46511. PubMed ID: 23071580
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy.
    Takemoto M; Node K; Nakagami H; Liao Y; Grimm M; Takemoto Y; Kitakaze M; Liao JK
    J Clin Invest; 2001 Nov; 108(10):1429-37. PubMed ID: 11714734
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of Thymosin β4 in angiotensin II-induced cardiomyocytes growth.
    Gupta S; Li L
    Expert Opin Biol Ther; 2018 Jul; 18(sup1):105-110. PubMed ID: 30063846
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Angiotensin II-induced p53-dependent cardiac apoptotic cell death: its prevention by metallothionein.
    Liu Q; Wang G; Zhou G; Tan Y; Wang X; Wei W; Liu L; Xue W; Feng W; Cai L
    Toxicol Lett; 2009 Dec; 191(2-3):314-20. PubMed ID: 19808082
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The RhoA/Rho kinase pathway in the myocardium.
    Peters SL; Michel MC
    Cardiovasc Res; 2007 Jul; 75(1):3-4. PubMed ID: 17499228
    [No Abstract]   [Full Text] [Related]  

  • 60. Angiotensin II-mediated adaptive and maladaptive remodeling of cardiomyocyte excitation-contraction coupling.
    Gusev K; Domenighetti AA; Delbridge LM; Pedrazzini T; Niggli E; Egger M
    Circ Res; 2009 Jul; 105(1):42-50. PubMed ID: 19478206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.